Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Fevertree (FEVR) Share Price

Price 845.00p on 21-07-2026 at 09:45:33
Change 30.00p 3.68%
Buy 846.50p
Sell 843.00p
Last Trade: Buy 71.00 at 845.60p
Day's Volume: 280,903
Last Close: 815.00p
Open: 820.00p
ISIN: GB00BRJ9BJ26
Day's Range 812.00p - 847.00p
52wk Range: 711.00p - 1,020.00p
Market Capitalisation: £953.02m
VWAP: 838.11866p
Shares in Issue: 112.78m

Fevertree (FEVR) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 71 845.60p Ordinary
10:45:32 - 21-Jul-26
Sell* 569 845.00p Automatic Execution
10:45:27 - 21-Jul-26
Sell* 651 845.00p Automatic Execution
10:45:27 - 21-Jul-26
Sell* 99 845.50p Automatic Execution
10:45:27 - 21-Jul-26
Sell* 98 845.50p Automatic Execution
10:45:27 - 21-Jul-26
Sell* 92 845.50p Automatic Execution
10:45:27 - 21-Jul-26
Sell* 91 845.50p Automatic Execution
10:45:27 - 21-Jul-26
Sell* 98 845.50p Automatic Execution
10:45:27 - 21-Jul-26
Sell* 9 845.50p Automatic Execution
10:45:27 - 21-Jul-26
Sell* 92 846.00p Automatic Execution
10:45:27 - 21-Jul-26
See more Fevertree trades

Fevertree (FEVR) Share Price History

Time period:
to
Date Open High Low Close Volume
20th Jul 2026 (Mon) 810.00 818.50 803.00 815.00 392,284
17th Jul 2026 (Fri) 806.00 825.00 806.00 812.50 244,776
16th Jul 2026 (Thu) 800.00 814.00 792.00 814.00 284,809
15th Jul 2026 (Wed) 785.00 800.00 776.00 798.50 281,963
14th Jul 2026 (Tue) 774.00 795.00 761.00 788.00 994,376
13th Jul 2026 (Mon) 780.00 783.00 767.00 774.00 243,366
10th Jul 2026 (Fri) 780.00 780.00 766.00 777.50 521,212
9th Jul 2026 (Thu) 750.00 766.50 745.00 766.00 485,531
8th Jul 2026 (Wed) 792.00 800.00 758.50 766.00 456,465
7th Jul 2026 (Tue) 819.00 819.00 779.00 788.50 764,690
6th Jul 2026 (Mon) 804.50 804.50 781.00 781.00 239,984
3rd Jul 2026 (Fri) 814.00 814.00 799.00 800.00 167,152
2nd Jul 2026 (Thu) 819.50 822.00 806.00 806.00 343,484
1st Jul 2026 (Wed) 815.50 821.50 799.50 817.50 291,983
30th Jun 2026 (Tue) 780.00 817.00 780.00 812.50 823,128
29th Jun 2026 (Mon) 780.00 823.00 780.00 810.00 1,484,296
26th Jun 2026 (Fri) 800.00 821.50 785.00 816.50 698,143
25th Jun 2026 (Thu) 832.00 832.00 809.50 825.50 427,691
24th Jun 2026 (Wed) 800.00 826.50 797.50 821.50 983,385
23rd Jun 2026 (Tue) 804.00 804.00 786.00 796.50 380,500
22nd Jun 2026 (Mon) 823.00 823.00 790.00 802.50 316,454
See more Fevertree price history

Fevertree (FEVR) Regulatory News

Date Source Headline
15th Jul 2026 7:00 am RNS Block Listing Return
14th Jul 2026 7:00 am RNS Transaction in Own Shares
7th Jul 2026 7:00 am RNS Transaction in Own Shares
1st Jul 2026 10:20 am RNS Total Voting Rights
1st Jul 2026 7:00 am RNS Update on share buyback extension
30th Jun 2026 9:42 am RNS Board Change
30th Jun 2026 7:00 am RNS Transaction in Own Shares
23rd Jun 2026 7:00 am RNS Transaction in Own Shares
16th Jun 2026 7:00 am RNS Transaction in Own Shares
9th Jun 2026 12:46 pm RNS Results of AGM
See more Fevertree regulatory news

Fevertree (FEVR) Share News

IN BRIEF: Fevertree Drinks starts GBP30 million buyback extension

1st Jul 2026 13:52

Fevertree Drinks PLC - London-based maker of premium drink mixers - Fevertree starts the GBP30 million extension of its share buyback programme, which it had announced at its annual general meeting last month. The new GBP30 million buyback follows a buyback of the same size completed earlier in the year. It begins on Wednesday and will be completed by December 31. It will be run by Investec Bank PLC. Read More

UK dividends calendar - next 7 days

19th Jun 2026 12:11

Read More

Fevertree Drinks extends share buyback after solid start to year

9th Jun 2026 11:26

(Alliance News) - Fevertree Drinks PLC on Tuesday announced a GBP30 million extension to its share buyback programme and said it remains confident of achieving full-year market expectations. Read More

LONDON BRIEFING: GSK agrees to buy US cancer drug maker Nuvalent

9th Jun 2026 07:58

(Alliance News) - GSK agrees to buy US cancer treatment firm Nuvalent for USD10.6 billion, AstraZeneca advances its own weight-loss treatment while Bellway reports an "increasingly challenging" housing market. Read More

UK shareholder meetings calendar - next 7 days

2nd Jun 2026 13:44

Read More

See more Fevertree news
FTSE 100 Latest
Value10,544.43
Change19.67

Login to your account

Forgot Password?

Not Registered